PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 17 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Tuberous rhizome lectin (KRL) inhibited growth of SW480 (67%) and SW48 (59%) cells at 1.0 mg/ml [PMID:31505204]
KRL inhibited cell growth (6.2-50.5%) in vitro [PMID:24449374]; a 21kDa lectin showed 43.7% growth inhibition in vitro at 160µg/ml [PMID:28461165].
K. rotunda-mediated silver/silver chloride nanoparticles inhibited A549 (IC50 59.7 µg/ml) and SMMC-7721 (IC50 126.3 µg/ml) cell lines [PMID:39290346]
K. rotunda-mediated Ag/AgCl-NPs inhibited 77.2% of GSCs growth at 32 µg/mL (IC50 6.8 µg/mL) [PMID:33047886]
Compound 12 from methanolic extract showed moderate cytotoxic activity against PSN-1 and MDA-MB231 lines [PMID:25111413]
Evidence summary
PubMed sources
- 1.PMID: 37765107 (2023) — Anti-Aging Potential of Plants of the Anak Dalam Tribe, Jambi, Indonesia. · Pharmaceuticals (Basel, Switzerland)
- 2.PMID: 20046746 (2008) — Evaluation of Antioxidant Potential of Kaempferia rotunda Linn. · Indian journal of pharmaceutical sciences
- 3.PMID: 39290346 (2024) — Asparagus racemosus silver chloride nanoparticles and Kaempferia rotunda mediated silver/silver chloride nanoparticles inhibit human hepatocellular and lung cancer cell lines. · Biochemistry and biophysics reports
- 4.PMID: 34814832 (2021) — Molecular evolution of chloroplast genomes in subfamily Zingiberoideae (Zingiberaceae). · BMC plant biology
- 5.PMID: 31505204 (2019)